CARTaGENE | OHS | BCGP | APATH | Alberta’s tomorrow project | PURE | MHI | First Nations | |
---|---|---|---|---|---|---|---|---|
Preliminary Selection Criteria of Participants | ||||||||
Yes | Yes | Yes | NA | Yes | NA | NA | NA | |
Blood Sample previously collected | Yes – also new sample | Yes | Yes – also new sample collected | Yes – also new sample collected | NA – obtaining new blood sample | Yes – new sample for Hamilton only | Yes – also new sample | NA – new sample |
Geographic Criteria | Metropolitan Montreal and Quebec City | Greater Toronto Area, London, Hamilton, Ottawa | Metro Vancouver | Halifax and surrounding area | Calgary and Edmonton | Hamilton, Vancouver, Quebec City | Montreal | Hazelton, Maskwacis, Lac La Ronge, Sandy Bay, Fort MacKay, Thunder Bay, Six Nations, Oneida, Wendat, Pictou Landing |
Prioritized Ethnic | African | South Asian, Chinese, African | East Asian, South Asian, Black | NA | NA | NA | NA | First Nations |
CVD (−) | Max 20 % can have history of: MI, stroke or cancer – if not then expand | Exclude: MI, stroke, CABG, PTCA, CHF, cancer | Max 20 % can have history of: MI, stroke, CABG, PTCA, CHF or cancer | Max 20 % can have history of: MI, stroke, CABG, PTCA, CHF or cancer | Max 20 % can have history of: MI, stroke, CABG, PTCA, CHF or cancer | Max 20 % can have history of: MI, stroke, CABG, PTCA, CHF or cancer | Max 20 % can have history of: MI, stroke, CABG, PTCA, CHF or cancer | Max 20 % can have history of: MI, stroke, CABG, PTCA, CHF or cancer |
Age | 35–69 years at time of entry | 35–69 years at time of entry | 35–69 years at time of entry | 35–69 years at time of entry | 35–69 years at time of entry | 35–69 years at time of entry | 35–69 years at time of entry | 18 years and up |
Additional Sampling after above criteria considered | ||||||||
Participant Selection | Random | Random | Random | Random | Random | Consecutive | Consecutive | Volunteer |
Cohort specific selection criteria | Prioritized for existing RNA sample and genomic information | Approach participants coming for in-person follow up visit | ||||||
Exclusions | Participants in the Diabetes/Depression substudy or with pacemaker | Recently invited to participate in other sub-studies | ||||||
Log of participant kept or available | Yes | Yes | Yes | Yes | Yes | Yes | Yes | NA |